Your browser doesn't support javascript.
loading
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.
Chan, Wei Yee; Howells, Lara; Wilson, William; Sanchez, Emilie; Ainley, Louise; Chavda, Selina J; Dowling, Emma; Correia, Nuno; Lecat, Catherine S Y; McMillan, Annabel; Wisniowski, Brendan; Mahmood, Shameem; Papanikolaou, Xenofon; Lee, Lydia; Sive, Jonathan; Kyriakou, Charalampia; Wechalekar, Ashutosh; Popat, Rakesh; Rabin, Neil; Nastouli, Eleni; Yong, Kwee L; Xu, Ke.
Afiliação
  • Chan WY; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Howells L; Research Department of Haematology, UCL Cancer Institute, London, UK.
  • Wilson W; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Sanchez E; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
  • Ainley L; Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Chavda SJ; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Dowling E; Research Department of Haematology, UCL Cancer Institute, London, UK.
  • Correia N; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Lecat CSY; Research Department of Haematology, UCL Cancer Institute, London, UK.
  • McMillan A; HCA Healthcare at University College London Hospitals NHS Foundation Trust, London, UK.
  • Wisniowski B; HCA Healthcare at University College London Hospitals NHS Foundation Trust, London, UK.
  • Mahmood S; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Papanikolaou X; Research Department of Haematology, UCL Cancer Institute, London, UK.
  • Lee L; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Sive J; Research Department of Haematology, UCL Cancer Institute, London, UK.
  • Kyriakou C; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Wechalekar A; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Popat R; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Rabin N; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Nastouli E; Research Department of Haematology, UCL Cancer Institute, London, UK.
  • Yong KL; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Xu K; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Br J Haematol ; 196(3): e21-e26, 2022 02.
Article em En | MEDLINE | ID: mdl-34632575
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Gamopatia Monoclonal de Significância Indeterminada / Vacinação / Mieloma Múltiplo Latente / SARS-CoV-2 / COVID-19 / Vacina BNT162 / ChAdOx1 nCoV-19 Limite: Aged / Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Gamopatia Monoclonal de Significância Indeterminada / Vacinação / Mieloma Múltiplo Latente / SARS-CoV-2 / COVID-19 / Vacina BNT162 / ChAdOx1 nCoV-19 Limite: Aged / Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article